Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer.

Dupuy F, Tabariès S, Andrzejewski S, Dong Z, Blagih J, Annis MG, Omeroglu A, Gao D, Leung S, Amir E, Clemons M, Aguilar-Mahecha A, Basik M, Vincent EE, St-Pierre J, Jones RG, Siegel PM.

Cell Metab. 2015 Oct 6;22(4):577-89. doi: 10.1016/j.cmet.2015.08.007. Epub 2015 Sep 10.

PMID:
26365179
2.

The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers.

Légaré S, Cavallone L, Mamo A, Chabot C, Sirois I, Magliocco A, Klimowicz A, Tonin PN, Buchanan M, Keilty D, Hassan S, Laperrière D, Mader S, Aleynikova O, Basik M.

Cancer Res. 2015 Oct 15;75(20):4351-63. doi: 10.1158/0008-5472.CAN-14-3475. Epub 2015 Aug 21.

PMID:
26297734
3.

A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer.

Hosein AN, Livingstone J, Buchanan M, Reid JF, Hallett M, Basik M.

BMC Cancer. 2015 Mar 15;15:130. doi: 10.1186/s12885-015-1117-0.

4.

Glycoproteomic comparison of clinical triple-negative and luminal breast tumors.

Hill JJ, Tremblay TL, Fauteux F, Li J, Wang E, Aguilar-Mahecha A, Basik M, O'Connor-McCourt M.

J Proteome Res. 2015 Mar 6;14(3):1376-88. doi: 10.1021/pr500987r. Epub 2015 Feb 16.

PMID:
25658377
5.

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.

Boileau JF, Poirier B, Basik M, Holloway CM, Gaboury L, Sideris L, Meterissian S, Arnaout A, Brackstone M, McCready DR, Karp SE, Trop I, Lisbona A, Wright FC, Younan RJ, Provencher L, Patocskai E, Omeroglu A, Robidoux A.

J Clin Oncol. 2015 Jan 20;33(3):258-64. doi: 10.1200/JCO.2014.55.7827. Epub 2014 Dec 1.

6.

Chromosome-breakage genomic instability and chromothripsis in breast cancer.

Przybytkowski E, Lenkiewicz E, Barrett MT, Klein K, Nabavi S, Greenwood CM, Basik M.

BMC Genomics. 2014 Jul 9;15:579. doi: 10.1186/1471-2164-15-579.

7.

Testing devices or experimental systems? Cancer clinical trials take the genomic turn.

Nelson NC, Keating P, Cambrosio A, Aguilar-Mahecha A, Basik M.

Soc Sci Med. 2014 Jun;111:74-83. doi: 10.1016/j.socscimed.2014.04.008. Epub 2014 Apr 12.

PMID:
24768778
8.

Imiquimod in the treatment of breast cancer skin metastasis.

Henriques L, Palumbo M, Guay MP, Bahoric B, Basik M, Kavan P, Batist G.

J Clin Oncol. 2014 Mar 10;32(8):e22-5. doi: 10.1200/JCO.2012.46.4883. Epub 2014 Jan 13. No abstract available.

9.

RSF1 and not cyclin D1 gene amplification may predict lack of benefit from adjuvant tamoxifen in high-risk pre-menopausal women in the MA.12 randomized clinical trial.

Keilty D, Buchanan M, Ntapolias K, Aleynikova O, Tu D, Li X, Shepherd L, Bramwell V, Basik M.

PLoS One. 2013 Dec 19;8(12):e81740. doi: 10.1371/journal.pone.0081740. eCollection 2013.

10.

Biopsies: next-generation biospecimens for tailoring therapy.

Basik M, Aguilar-Mahecha A, Rousseau C, Diaz Z, Tejpar S, Spatz A, Greenwood CM, Batist G.

Nat Rev Clin Oncol. 2013 Aug;10(8):437-50. doi: 10.1038/nrclinonc.2013.101. Epub 2013 Jun 25. Review. Erratum in: Nat Rev Clin Oncol. 2013 Nov;10(11):608.

PMID:
23799370
11.

Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine.

Diaz Z, Aguilar-Mahecha A, Paquet ER, Basik M, Orain M, Camlioglu E, Constantin A, Benlimame N, Bachvarov D, Jannot G, Simard MJ, Chabot B, Gologan A, Klinck R, Gagnon-Kugler T, Lespérance B, Samson B, Kavan P, Alcindor T, Dalfen R, Lan C, Chabot C, Buchanan M, Przybytkowski E, Qureshi S, Rousseau C, Spatz A, Têtu B, Batist G.

Mod Pathol. 2013 Nov;26(11):1413-24. doi: 10.1038/modpathol.2013.81. Epub 2013 Jun 7.

12.

Monoallelic chromatin conformation flanking long-range silenced domains in cancer-derived and normal cells.

Di Paola D, Raelson J, Rampakakis E, Basik M, Zannis-Hadjopoulos M, Bradley WE.

PLoS One. 2013 May 16;8(5):e63190. doi: 10.1371/journal.pone.0063190. Print 2013.

13.

Endoplasmic reticulum stress induces PRNP prion protein gene expression in breast cancer.

Déry MA, Jodoin J, Ursini-Siegel J, Aleynikova O, Ferrario C, Hassan S, Basik M, LeBlanc AC.

Breast Cancer Res. 2013 Mar 12;15(2):R22. doi: 10.1186/bcr3398.

14.

Ultradense array CGH and discovery of micro-copy number alterations and gene fusions in the cancer genome.

Przybytkowski E, Aguilar-Mahecha A, Nabavi S, Tonellato PJ, Basik M.

Methods Mol Biol. 2013;973:15-38. doi: 10.1007/978-1-62703-281-0_2.

15.

Making sense of intratumor genetic heterogeneity: altered frequency of androgen receptor CAG repeat length variants in breast cancer tissues.

Gottlieb B, Alvarado C, Wang C, Gharizadeh B, Babrzadeh F, Richards B, Batist G, Basik M, Beitel LK, Trifiro M.

Hum Mutat. 2013 Apr;34(4):610-8. doi: 10.1002/humu.22287. Epub 2013 Mar 8.

PMID:
23377847
16.

Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration.

Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, Buchanan M, Hosein AN, Basik M, Wrana JL.

Cell. 2012 Dec 21;151(7):1542-56. doi: 10.1016/j.cell.2012.11.024.

17.

The effect of pre-analytical variability on the measurement of MRM-MS-based mid- to high-abundance plasma protein biomarkers and a panel of cytokines.

Aguilar-Mahecha A, Kuzyk MA, Domanski D, Borchers CH, Basik M.

PLoS One. 2012;7(6):e38290. doi: 10.1371/journal.pone.0038290. Epub 2012 Jun 6.

18.

Claudin-2 promotes breast cancer liver metastasis by facilitating tumor cell interactions with hepatocytes.

Tabariès S, Dupuy F, Dong Z, Monast A, Annis MG, Spicer J, Ferri LE, Omeroglu A, Basik M, Amir E, Clemons M, Siegel PM.

Mol Cell Biol. 2012 Aug;32(15):2979-91. doi: 10.1128/MCB.00299-12. Epub 2012 May 29.

19.

Sef downregulation by Ras causes MEK1/2 to become aberrantly nuclear localized leading to polyploidy and neoplastic transformation.

Duhamel S, Hébert J, Gaboury L, Bouchard A, Simon R, Sauter G, Basik M, Meloche S.

Cancer Res. 2012 Feb 1;72(3):626-35. doi: 10.1158/0008-5472.CAN-11-2126.

20.

Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell lines.

Ha KC, Lalonde E, Li L, Cavallone L, Natrajan R, Lambros MB, Mitsopoulos C, Hakas J, Kozarewa I, Fenwick K, Lord CJ, Ashworth A, Vincent-Salomon A, Basik M, Reis-Filho JS, Majewski J, Foulkes WD.

BMC Med Genomics. 2011 Oct 27;4:75. doi: 10.1186/1755-8794-4-75.

Items per page

Supplemental Content

Write to the Help Desk